Skip to main content
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 Jan;2(1):35–39. doi: 10.1128/cdli.2.1.35-39.1995

Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay.

M E Helminen 1, R Beach 1, I Maciver 1, G Jarosik 1, E J Hansen 1, M Leinonen 1
PMCID: PMC170097  PMID: 7719910

Abstract

The role of Moraxella (Branhamella) catarrhalis as a respiratory tract pathogen is increasingly recognized. We looked at the human immune response against individual outer membrane proteins of M. catarrhalis and against the 81-kDa CopB protein, which has previously been shown to be a target for protective antibodies. Paired serum samples from six elderly patients with pneumonia were tested by Western blot (immunoblot) analysis by using outer membrane vesicles of M. catarrhalis 035E as antigen. All of the six convalescent-phase serum samples reacted with a protein which migrated at the position of the CopB protein and with a high-molecular-weight protein of M. catarrhalis; three serum samples also reacted with a 34-kDa outer membrane protein. Paired serum samples from 18 patients, 10 of which had M. catarrhalis infection on the basis of previous serology results, were tested by enzyme immunoassay (EIA) with the CopB protein and whole cells of M. catarrhalis 035E as antigens. Nine patients showed a significant rise in EIA titer between acute- and convalescent-phase sera when whole bacterial cells were used as antigens. Six (67%) patient samples that were positive by the EIA with the whole-cell antigen were also positive by the EIA with the CopB antigen, and six of nine patient samples negative by the EIA with the whole-cell antigen were also negative by the EIA with the CopB antigen. These results suggest that both the CopB and a high-molecular-weight protein are major targets of the immune response against M. catarrhalis, and further studies with greater amounts of patient materials are needed to elucidate the usefulness of CopB as an antigen in etiologic studies.

Full Text

The Full Text of this article is available as a PDF (443.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartos L. C., Murphy T. F. Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis. J Infect Dis. 1988 Oct;158(4):761–765. doi: 10.1093/infdis/158.4.761. [DOI] [PubMed] [Google Scholar]
  2. Black A. J., Wilson T. S. Immunoglobulin G (IgG) serological response to Branhamella catarrhalis in patients with acute bronchopulmonary infections. J Clin Pathol. 1988 Mar;41(3):329–333. doi: 10.1136/jcp.41.3.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brorson J. E., Axelsson A., Holm S. E. Studies on Branhamella Catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand J Infect Dis. 1976;8(3):151–155. doi: 10.3109/inf.1976.8.issue-3.05. [DOI] [PubMed] [Google Scholar]
  4. Burman L. A., Leinonen M., Trollfors B. Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis. J Infect Dis. 1994 Jul;170(1):220–222. doi: 10.1093/infdis/170.1.220. [DOI] [PubMed] [Google Scholar]
  5. Catlin B. W. Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin Microbiol Rev. 1990 Oct;3(4):293–320. doi: 10.1128/cmr.3.4.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chapman A. J., Jr, Musher D. M., Jonsson S., Clarridge J. E., Wallace R. J., Jr Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis. 1985 May;151(5):878–882. doi: 10.1093/infdis/151.5.878. [DOI] [PubMed] [Google Scholar]
  7. Claesson B. A., Lagergård T., Trollfors B., Gothefors L., Jodal U. Serum antibody response to capsular polysaccharide, outer membrane, and lipooligosaccharide in children with invasive Haemophilus influenzae type b infections. J Clin Microbiol. 1987 Dec;25(12):2339–2343. doi: 10.1128/jcm.25.12.2339-2343.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davies B. I., Maesen F. P. The epidemiology of respiratory tract pathogens in southern Netherlands. Eur Respir J. 1988 May;1(5):415–420. [PubMed] [Google Scholar]
  9. Diamond L. A., Lorber B. Branhamella catarrhalis pneumonia and immunoglobulin abnormalities: a new association. Am Rev Respir Dis. 1984 May;129(5):876–878. doi: 10.1164/arrd.1984.129.5.876. [DOI] [PubMed] [Google Scholar]
  10. Dickinson D. P., Loos B. G., Dryja D. M., Bernstein J. M. Restriction fragment mapping of Branhamella catarrhalis: a new tool for studying the epidemiology of this middle ear pathogen. J Infect Dis. 1988 Jul;158(1):205–208. doi: 10.1093/infdis/158.1.205. [DOI] [PubMed] [Google Scholar]
  11. Faden H., Hong J., Murphy T. Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect Immun. 1992 Sep;60(9):3824–3829. doi: 10.1128/iai.60.9.3824-3829.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Faden H., Waz M. J., Bernstein J. M., Brodsky L., Stanievich J., Ogra P. L. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol. 1991 Aug;100(8):612–615. doi: 10.1177/000348949110000802. [DOI] [PubMed] [Google Scholar]
  13. Goldblatt D., Seymour N. D., Levinsky R. J., Turner M. W. An enzyme-linked immunosorbent assay for the determination of human IgG subclass antibodies directed against Branhamella catarrhalis. J Immunol Methods. 1990 Apr 17;128(2):219–225. doi: 10.1016/0022-1759(90)90213-f. [DOI] [PubMed] [Google Scholar]
  14. Goldblatt D., Turner M. W., Levinsky R. J. Branhamella catarrhalis: antigenic determinants and the development of the IgG subclass response in childhood. J Infect Dis. 1990 Nov;162(5):1128–1135. doi: 10.1093/infdis/162.5.1128. [DOI] [PubMed] [Google Scholar]
  15. Gray B. M., Converse G. M., 3rd, Huhta N., Johnston R. B., Jr, Pichichero M. E., Schiffman G., Dillon H. C., Jr Epidemiologic studies of Streptococcus pneumoniae in infants: antibody response to nasopharyngeal carriage of types 3, 19, and 23. J Infect Dis. 1981 Oct;144(4):312–318. doi: 10.1093/infdis/144.4.312. [DOI] [PubMed] [Google Scholar]
  16. Helminen M. E., Maciver I., Latimer J. L., Cope L. D., McCracken G. H., Jr, Hansen E. J. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect Immun. 1993 May;61(5):2003–2010. doi: 10.1128/iai.61.5.2003-2010.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Helminen M. E., Maciver I., Paris M., Latimer J. L., Lumbley S. L., Cope L. D., McCracken G. H., Jr, Hansen E. J. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo. J Infect Dis. 1993 Nov;168(5):1194–1201. doi: 10.1093/infdis/168.5.1194. [DOI] [PubMed] [Google Scholar]
  18. Jousimies-Somer H. R., Savolainen S., Ylikoski J. S. Comparison of the nasal bacterial floras in two groups of healthy subjects and in patients with acute maxillary sinusitis. J Clin Microbiol. 1989 Dec;27(12):2736–2743. doi: 10.1128/jcm.27.12.2736-2743.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jönsson I., Holme T., Krook A., Rahman M., Thorén M. Variability of surface-exposed antigens of different strains of Moraxella catarrhalis. Eur J Clin Microbiol Infect Dis. 1992 Oct;11(10):919–922. doi: 10.1007/BF01962374. [DOI] [PubMed] [Google Scholar]
  20. Kerttula Y., Leinonen M., Koskela M., Mäkelä P. H. The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods. J Infect. 1987 Jan;14(1):21–30. doi: 10.1016/s0163-4453(87)90730-4. [DOI] [PubMed] [Google Scholar]
  21. Kimura A., Gulig P. A., McCracken G. H., Jr, Loftus T. A., Hansen E. J. A minor high-molecular-weight outer membrane protein of Haemophilus influenzae type b is a protective antigen. Infect Immun. 1985 Jan;47(1):253–259. doi: 10.1128/iai.47.1.253-259.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Klingman K. L., Murphy T. F. Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis. Infect Immun. 1994 Apr;62(4):1150–1155. doi: 10.1128/iai.62.4.1150-1155.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Korppi M., Katila M. L., Jäskeläinen J., Leinonen M. Role of Moraxella (Branhamella) catarrhalis as a respiratory pathogen in children. Acta Paediatr. 1992 Dec;81(12):993–996. doi: 10.1111/j.1651-2227.1992.tb12161.x. [DOI] [PubMed] [Google Scholar]
  24. Leinonen M., Luotonen J., Herva E., Valkonen K., Mäkelä P. H. Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. J Infect Dis. 1981 Dec;144(6):570–574. doi: 10.1093/infdis/144.6.570. [DOI] [PubMed] [Google Scholar]
  25. Maciver I., Unhanand M., McCracken G. H., Jr, Hansen E. J. Effect of immunization of pulmonary clearance of Moraxella catarrhalis in an animal model. J Infect Dis. 1993 Aug;168(2):469–472. doi: 10.1093/infdis/168.2.469. [DOI] [PubMed] [Google Scholar]
  26. Murphy T. F., Bartos L. C. Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis. Infect Immun. 1989 Oct;57(10):2938–2941. doi: 10.1128/iai.57.10.2938-2941.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Murphy T. F., Kirkham C., Lesse A. J. The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis. Mol Microbiol. 1993 Oct;10(1):87–97. doi: 10.1111/j.1365-2958.1993.tb00906.x. [DOI] [PubMed] [Google Scholar]
  28. Murphy T. F., Loeb M. R. Isolation of the outer membrane of Branhamella catarrhalis. Microb Pathog. 1989 Mar;6(3):159–174. doi: 10.1016/0882-4010(89)90066-1. [DOI] [PubMed] [Google Scholar]
  29. Murphy T. F. The surface of Branhamella catarrhalis: a systematic approach to the surface antigens of an emerging pathogen. Pediatr Infect Dis J. 1989 Jan;8(1 Suppl):S75–S77. [PubMed] [Google Scholar]
  30. Norkus S. J., Vennes J. W. Labile type-specific antigen of Moraxella catarrhalis. J Clin Microbiol. 1990 Dec;28(12):2815–2817. doi: 10.1128/jcm.28.12.2815-2817.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Patterson T. F., Patterson J. E., Masecar B. L., Barden G. E., Hierholzer W. J., Jr, Zervos M. J. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J Infect Dis. 1988 May;157(5):996–1001. doi: 10.1093/infdis/157.5.996. [DOI] [PubMed] [Google Scholar]
  32. Robertson S. M., Frisch C. F., Gulig P. A., Kettman J. R., Johnston K. H., Hansen E. J. Monoclonal antibodies directed against a cell surface-exposed outer membrane protein of Haemophilus influenzae type b. Infect Immun. 1982 Apr;36(1):80–88. doi: 10.1128/iai.36.1.80-88.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ruuskanen O., Arola M., Putto-Laurila A., Mertsola J., Meurman O., Viljanen M. K., Halonen P. Acute otitis media and respiratory virus infections. Pediatr Infect Dis J. 1989 Feb;8(2):94–99. [PubMed] [Google Scholar]
  34. Shurin P. A., Marchant C. D., Kim C. H., Van Hare G. F., Johnson C. E., Tutihasi M. A., Knapp L. J. Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. Pediatr Infect Dis. 1983 Jan-Feb;2(1):34–38. doi: 10.1097/00006454-198301000-00009. [DOI] [PubMed] [Google Scholar]
  35. Unhanand M., Maciver I., Ramilo O., Arencibia-Mireles O., Argyle J. C., McCracken G. H., Jr, Hansen E. J. Pulmonary clearance of Moraxella catarrhalis in an animal model. J Infect Dis. 1992 Apr;165(4):644–650. doi: 10.1093/infdis/165.4.644. [DOI] [PubMed] [Google Scholar]
  36. Van Hare G. F., Shurin P. A., Marchant C. D., Cartelli N. A., Johnson C. E., Fulton D., Carlin S., Kim C. H. Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis. 1987 Jan-Feb;9(1):16–27. doi: 10.1093/clinids/9.1.16. [DOI] [PubMed] [Google Scholar]
  37. Vaneechoutte M., Verschraegen G., Claeys G., Van Den Abeele A. M. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens. J Clin Microbiol. 1990 Feb;28(2):182–187. doi: 10.1128/jcm.28.2.182-187.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wright P. W., Wallace R. J., Jr Pneumonia due to Moraxella (Branhamella) catarrhalis. Semin Respir Infect. 1989 Mar;4(1):40–46. [PubMed] [Google Scholar]
  39. Yamanaka N., Faden H. Antibody response to outer membrane protein of nontypeable Haemophilus influenzae in otitis-prone children. J Pediatr. 1993 Feb;122(2):212–218. doi: 10.1016/s0022-3476(06)80115-0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES